Francisco Díaz
Instituto Politécnico Nacional
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Francisco Díaz.
Journal of Pharmacy and Pharmacology | 1999
Fernando Labarrios; Leticia Garduño; Maria Del Rosario Vidal; Raúl García; María Salazar; Elizdath Martínez; Francisco Díaz; Germán Chamorro; Joaquín Tamariz
A series of α‐asarone analogues related to clofibrate, containing an acetic acid group at C‐2 of the aromatic ring, has been prepared as the acids or as the ethyl and methyl esters. The corresponding alcohols were also synthesized by reduction of the ethyl esters. The compounds were examined in hyperlipidaemic male mice to evaluate their ability to modify serum lipoprotein cholesterol, low‐density lipoprotein cholesterol, high‐density lipoprotein cholesterol and triglycerides after oral administration of 40 and 80 mg kg−1 for 6 days.
Drug Development Research | 1998
Germán Chamorro; Leticia Garduño; Adrián Sánchez; Fernando Labarrios; María Salazar; Elizdath Martínez; Francisco Díaz; Joaquín Tamariz
The hypolipidaemic activity of several dimethoxy unconjugated propenyl side‐chain analogs of α‐asarone were investigated in hyperlipidaemic mice after six days of treatment. Eugenol and the α‐asarone analog with amino groups on the C‐4 position of the aromatic ring were observed to be the most effective hypolipidaemic agents at the dose of 80 mg/kg/day p.o. These compounds significantly lowered total serum cholesterol, low density lipoprotein (LDL‐cholesterol), and triglycerides content. On the other hand, high density lipoprotein (HDL‐cholesterol) was increased by administration of these hypolipidaemic agents. The ability to modulate the levels of these lipids suggests that these agents could be effective in the treatment of hyperlipidaemic states. These compounds appeared to be safe when administered at an oral dose of 80 mg/kg/day, which is within the therapeutic range in mice. Drug Dev. Res. 43:105–108, 1998.
Phytotherapy Research | 1999
Germán Chamorro; María Salazar; Joaquín Tamariz; Francisco Díaz; Fernando Labarrios
Dominant lethal studies were conducted in male and female mice with α‐asarone, the active hypolipidaemic component of Guatteria gaumeri Greenman, by per os sub‐chronic treatment (10 and 20 mg/kg, 5 days/week, for 8 weeks) and subsequent mating. α‐Asarone did not produce germinal mutations in either males or females. Epididymal sperm examination of male mice immediately after treatment failed toreveal any alteration in sperm count on shape. No significant alterations were observed in testicular or epididymal weights or testicular histology. Copyright
Organic Preparations and Procedures International | 1991
Francisco Díaz; Leticia Contreras; Rosa Flores; Joaquín Tamariz; Fernando Labarrios; Germán Chamorro; Héber Muñoz
Drug Development Research | 2004
Dolores Hernández; Pablo Bernal; Adriana Cruz; Yésica Garciafigueroa; Leticia Garduño; María Salazar; Francisco Díaz; Germán Chamorro; Joaquín Tamariz
Biomedica | 2009
Lauro Figueroa; Francisco Díaz; Abelardo Camacho; Eliseo Díaz; Rolando Marvin
Medicinal Chemistry Research | 2001
Adriana Cruz; Leticia Garduño; María Salazar; Elizdath Martínez; Francisco Díaz; Germán Chamorro; Joaquín Tamariz
Drug Development Research | 2003
María del Carmen Cruz; María Salazar; Yésica Garciafigueroa; Dolores Hernández; Francisco Díaz; Germán Chamorro; Joaquín Tamariz
Drug Research | 2011
Adriana Cruz; Leticia Garduño; María Salazar; Elizdath Martínez; Hugo A. Jiménez-Vázquez; Francisco Díaz; Germán Chamorro; Joaquín Tamariz
ChemInform | 1994
Francisco Díaz; H. Munoz; Fernando Labarrios; Germán Chamorro; M. Salazar; M. E. Morelos; Joaquín Tamariz